Zhao Wenjing, Liu Shanglong, Cong Lin, Zhao Yupei
Central Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.
Department of General Surgery, Affiliated Hospital of Qingdao University, Shandong, China.
Ann Surg Oncol. 2022 Feb;29(2):1297-1312. doi: 10.1245/s10434-021-10662-2. Epub 2021 Sep 23.
The consensus guidelines for branch-duct intraductal papillary mucinous neoplasm (BD-IPMN) of the pancreas are mostly based on imaging features. This study aimed to determine imaging features and their diagnostic accuracy for predicting high-grade dysplasia (HGD)/malignancy in BD-IPMN, including mixed type.
The PubMed, Embase, and Cochrane databases were searched, and data were extracted from relevant studies. As the main diagnostic accuracy index, diagnostic odds ratios (DORs) of imaging features for diagnosing HGD/malignancy in BD-IPMNs were pooled using the random-effects model. A bivariate random-effects approach was used to construct summary receiver operating characteristic curves for sensitivity and specificity estimation.
The pooled DOR was the highest for the enhanced solid component/mural nodule (MN) (DOR, 12.21; 95 % confidence interval [CI], 6.14-24.27), followed by a main pancreatic duct (MPD) diameter of 10 mm or greater (DOR, 7.93; 95 % CI, 3.02-20.83), solid component (DOR, 4.85; 95 % CI, 2.49-9.42), lymphadenopathy (DOR, 4.84; 95 % CI, 1.11-21.06), MN (DOR, 4.48; 95 % CI, 3.15-6.39), an MPD diameter of 5 mm or greater (DOR, 3.69; 95 % CI, 2.62-5.19), abrupt change in MPD caliber with distal pancreatic atrophy (DOR, 2.65; 95 % CI, 1.66-4.24), thickened/enhancing walls (DOR, 2.38; 95 % CI, 1.57-3.60), and cyst size of 3 cm or larger (DOR, 1.98; 95 % CI, 1.48-2.64). The largest area under the curve (0.89 and 0.95, respectively) and high specificity (0.95 and 0.98, respectively) also were found for enhanced solid component/MN and an MPD diameter of 10 mm or greater, albeit with low sensitivity (0.38 and 0.14, respectively).
The aforementioned imaging features could aid in predicting HGD/malignancy of BD-IPMN. Furthermore, enhanced solid component/MN and an MPD diameter of 10 mm or greater were the most important predictors of HGD/malignancy in BD-IPMN and should be considered as indications for surgery.
胰腺分支导管内乳头状黏液性肿瘤(BD-IPMN)的共识指南大多基于影像学特征。本研究旨在确定BD-IPMN(包括混合型)中预测高级别异型增生(HGD)/恶性肿瘤的影像学特征及其诊断准确性。
检索PubMed、Embase和Cochrane数据库,并从相关研究中提取数据。作为主要诊断准确性指标,采用随机效应模型汇总BD-IPMN中诊断HGD/恶性肿瘤的影像学特征的诊断比值比(DOR)。采用双变量随机效应方法构建汇总的受试者工作特征曲线,以估计敏感性和特异性。
增强实性成分/壁结节(MN)的汇总DOR最高(DOR,12.21;95%置信区间[CI],6.14-24.27),其次是主胰管(MPD)直径≥10 mm(DOR,7.93;95%CI,3.02-20.83)、实性成分(DOR,4.85;95%CI,2.49-9.42)、淋巴结病(DOR,4.84;95%CI,1.11-21.06)、MN(DOR,4.48;95%CI,3.15-6.39)、MPD直径≥5 mm(DOR,3.69;95%CI,2.62-5.19)、MPD管径突然改变伴胰腺远端萎缩(DOR,2.65;95%CI,1.66-4.24)、壁增厚/强化(DOR,2.38;95%CI,1.57-3.60)以及囊肿大小≥3 cm(DOR,1.98;95%CI,1.48-2.64)。增强实性成分/MN和MPD直径≥10 mm的曲线下面积最大(分别为0.89和0.95),特异性也较高(分别为0.95和0.98),尽管敏感性较低(分别为0.38和0.14)。
上述影像学特征有助于预测BD-IPMN的HGD/恶性肿瘤。此外,增强实性成分/MN和MPD直径≥10 mm是BD-IPMN中HGD/恶性肿瘤最重要的预测指标,应被视为手术指征。